Hampe CS - Search Results

1

Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.

Maioli M, Alejandro E, Tonolo G, Gilliam LK, Bekris L, Hampe CS, Obinu DA, Manconi A, Puddu L, Lynch K, Lernmark A; Study Group for the Genetics of Diabetes in Sardinia. Maioli M, et al. Among authors: hampe cs. J Clin Endocrinol Metab. 2004 Nov;89(11):5675-82. doi: 10.1210/jc.2004-0864. J Clin Endocrinol Metab. 2004. PMID: 15531528

2

Species-specific autoantibodies in type 1 diabetes.

Hampe CS, Ortqvist E, Rolandsson O, Landin-Olsson M, Törn C, Agren A, Persson B, Schranz DB, Lernmark A. Hampe CS, et al. J Clin Endocrinol Metab. 1999 Feb;84(2):643-8. doi: 10.1210/jcem.84.2.5503. J Clin Endocrinol Metab. 1999. PMID: 10022431

3

Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations.

Hao W, Davis C, Daniels T, Hampe CS, Lernmark A. Hao W, et al. Among authors: hampe cs. Transfus Med. 1999 Dec;9(4):307-10. doi: 10.1046/j.1365-3148.1999.00214.x. Transfus Med. 1999. PMID: 10583884

4

Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes.

Hampe CS, Ortqvist E, Persson B, Schranz DB, Lernmark A. Hampe CS, et al. Horm Metab Res. 1999 Oct;31(10):553-7. doi: 10.1055/s-2007-978794. Horm Metab Res. 1999. PMID: 10596964

5

Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function.

Novak EJ, Ortqvist E, Nord E, Edwall L, Hampe CS, Bekris L, Persson BE, Lernmark A. Novak EJ, et al. Among authors: hampe cs. Diabetes Care. 2000 Jul;23(7):1019-21. doi: 10.2337/diacare.23.7.1019. Diabetes Care. 2000. PMID: 10895858 No abstract available.

6

Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A. Hampe CS, et al. J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9. doi: 10.1210/jcem.85.12.7070. J Clin Endocrinol Metab. 2000. PMID: 11134126 Clinical Trial.

7

A novel monoclonal antibody specific for the N-terminal end of GAD65.

Hampe CS, Lundgren P, Daniels TL, Hammerle LP, Marcovina SM, Lernmark A. Hampe CS, et al. J Neuroimmunol. 2001 Feb 1;113(1):63-71. doi: 10.1016/s0165-5728(00)00423-9. J Neuroimmunol. 2001. PMID: 11137577

8

Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.

Hampe CS, Hammerle LP, Falorni A, Robertson J, Lernmark A. Hampe CS, et al. FEBS Lett. 2001 Jan 19;488(3):185-9. doi: 10.1016/s0014-5793(00)02429-7. FEBS Lett. 2001. PMID: 11163769 Free article.

9

Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.

Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A. Hampe CS, et al. J Autoimmun. 2002 Feb;18(1):49-53. doi: 10.1006/jaut.2001.0564. J Autoimmun. 2002. PMID: 11869046

10

Preservation of enzyme activity and antigenicity after mutagenesis of the membrane anchoring domain of GAD65.

Plesner A, Hampe CS, Daniels TL, Hammerle LP, Lernmark A. Plesner A, et al. Among authors: hampe cs. Autoimmunity. 2001;34(4):221-30. doi: 10.3109/08916930109014691. Autoimmunity. 2001. PMID: 11905848 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters